Exploring the role of advanced oxidation processes in microplastics pollution research: A systematic literature review
Abstract
Advanced oxidation processes (AOPs) are a promising tool for microplastics (MPs) pollution research, with applications in aging, degradation, digestion, adsorption, and desorption processes. Therefore, this review aimed to identify the main applications of AOPs and the findings from MPs studies. The systematic literature review was conducted using the Web of Science database, which retrieved 388 articles between 1990 and November 2nd, 2025. After screening and eligibility analysis, 84 articles were deemed eligible for inclusion in the final review. Fenton agents, H2O2, and their combinations were predominant in studies on MPs aging, degradation, and digestion, accounting for approximately 89.2% of the studies. Persulfate was the most effective oxidizing agent for aging, rapidly causing morphological and chemical modifications, including surface cracks averaging 206 nm. In contrast, degradation of highly resistant MPs requires more robust technologies to achieve 95.9% degradation in a hydrothermal process with lower energy consumption. In digestion protocols, NaClO achieved 88-92.1% organic matter removal while causing less damage to MPs. However, recovery rates revealed challenges with PVC and PET particles (24 - 93%), varying substantially with the type of matrix, polymer, and oxidant. The AOPs can also modify the surface of MPs, increasing the number of functional groups and altering their interactions with pollutants. Overall, this review demonstrates that although AOPs…
How strong is the evidence?
Evidence Hub reads this as a systematic review. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.